Literature DB >> 15837100

Role of Terminalia arjuna in ischaemic mitral regurgitation.

S Dwivedi, A Aggarwal, M P Agarwal, S Rajpal.   

Abstract

The bark powder of Terminalia arjuna, an indigenous plant has been found to have antianginal, decongestive and hypolipidemic effect. We planned a study to evaluate the role of T. arjuna in ischemic mitral regurgitation (IMR) following acute myocardial infarction (AMI). 40 patients with fresh AMI showing IMR were randomly divided into 2 groups of 20 each. They were given placebo or 500 mg of T. arjuna in addition to anti-ischemic treatment. After 1 and 3 months of follow up, patients receiving adjuvant T. arjuna showed significant decrease in IMR, improvement in E/A ratio and considerable reduction in anginal frequency.

Entities:  

Mesh:

Year:  2005        PMID: 15837100     DOI: 10.1016/j.ijcard.2004.10.045

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Anti-Atherogenic Activity of Ethanolic Fraction of Terminalia arjuna Bark on Hypercholesterolemic Rabbits.

Authors:  Saravanan Subramaniam; Ramachandran Subramaniam; Suja Rajapandian; Subasini Uthrapathi; Victor Rajamanickam Gnanamanickam; Govinda Prasad Dubey
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-20       Impact factor: 2.629

Review 2.  Terminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis.

Authors:  Navjot Kaur; Nusrat Shafiq; Harish Negi; Avaneesh Pandey; Srinivas Reddy; Harpreet Kaur; Neelima Chadha; Samir Malhotra
Journal:  Cardiol Res Pract       Date:  2014-01-30       Impact factor: 1.866

Review 3.  Revisiting Terminalia arjuna - An Ancient Cardiovascular Drug.

Authors:  Shridhar Dwivedi; Deepti Chopra
Journal:  J Tradit Complement Med       Date:  2014-10

Review 4.  Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review.

Authors:  Augustine Amalraj; Sreeraj Gopi
Journal:  J Tradit Complement Med       Date:  2016-03-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.